Related Experiment Video
Updated: Jul 9, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations
Pushkar Malakar1, Sudhanshu Shukla2, Meghna Mondal1
1Department of Biomedical Science and Technology, School of Biological Sciences, Ramakrishna Mission Vivekananda Educational Research Institute (RKMVERI), Kolkata, India.
Abstract:
The process of alternative splicing (AS) is widely deregulated in a variety of cancers. Splicing is dependent upon splicing factors. Recently, several long noncoding RNAs (lncRNAs) have been shown to regulate AS by directly/indirectly interacting with splicing factors. This review focuses on the regulation of AS by lncRNAs through their interaction with splicing factors. AS mis-regulation caused by either mutation in splicing factors or deregulated expression of splicing factors and lncRNAs has been shown to be involved in cancer development and progression, making aberrant splicing, splicing factors and lncRNA suitable targets for cancer therapy. This review also addresses some of the current approaches used to target AS, splicing factors and lncRNAs. Finally, we discuss research challenges, some of the unanswered questions in the field and provide recommendations to advance understanding of the nexus of lncRNAs, AS and splicing factors in cancer.
Insights
Long noncoding RNAs (lncRNAs) regulate alternative splicing (AS) by interacting with splicing factors. Dysregulated AS, splicing factors, and lncRNAs are implicated in cancer, offering therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Alternative splicing (AS) is frequently dysregulated in various cancers.
- Splicing processes are critically dependent on splicing factors.
- Long noncoding RNAs (lncRNAs) are emerging regulators of AS through interactions with splicing factors.
Purpose of the Study:
- To review the mechanisms by which lncRNAs regulate AS via splicing factors.
- To explore the role of AS, splicing factors, and lncRNAs in cancer development and progression.
- To discuss therapeutic strategies targeting these components in cancer.
Main Methods:
- Literature review focusing on lncRNA-splicing factor interactions.
- Analysis of the role of aberrant splicing in oncogenesis.
- Examination of current therapeutic approaches targeting AS and related factors.
Main Results:
- lncRNAs modulate AS by directly or indirectly interacting with splicing factors.
- Mis-regulation of splicing factors and lncRNAs contributes to cancer development.
- Aberrant splicing, splicing factors, and lncRNAs represent promising therapeutic targets.
Conclusions:
- Understanding the interplay between lncRNAs, AS, and splicing factors is crucial for cancer therapy.
- Targeting these elements offers potential for novel cancer treatment strategies.
- Further research is needed to address current challenges and unanswered questions in the field.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Chromatin Structure and RNA Splicing
Pre-mRNA Processing: RNA Splicing
What is Gene Expression?

